To determine safety and efficacy of Cap. Hintosulin in drug naïve pre-diabetics and in Type-2 Diabetic patients on OHA
Not Applicable
Completed
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/09/021126
- Lead Sponsor
- Ishaana Nutraceutical Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subject having BSL (F) between 100 and 125 and is not a known diabeticOR subject is a known case of T2DM and is on oral anti-diabetic treatment
2.No change in anti-diabetic treatment for the last one month if not detected DM in last month
3.Between Age group of 18 and 70 years
4.Both male and female patients will be included
Exclusion Criteria
1.Diabetes other than type 2 diabetes mellitus
2.Patients having complications of diabetes like diabetic neuropathy, retinopathy, nephropathy, ketoacidosis.
3.Participation in any other clinical trial within the last 30 days
4.Pregnant or breast-feeding woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method